MCAM and cancer: It was intriguing that the serum METCAM/MUC18 concentrations appeared to increase with increasing Gleason scores, suggesting that serum METCAM/MUC18 concentrations increased with increasing pathological stages and perhaps with the increasing degree of malignancy of the cancer.